AquaBounty Technologies (LON:ABTU) has initiated field trials of its AquaAdvantage genetically modified salmon in Brazil and Argentina. 

Its genetically modified salmon have already been approved for sale in the US and Canada, the group is now seeking other markets.

"We are making the necessary preparations for the commercial launch of our product and we look forward to bringing our more sustainably produced salmon to consumers, with the assurance that it is nutritious, safe and healthy,” said chief executive Ron Stotish.
Read the full story

Have you listened to this article via the audio player above?

If so, send us your feedback around what we can do to improve this feature or further develop it. If not, check it out and let us know what you think via email or on social media.

A collection of stories from guest authors.

Join the Conversation